Title: "Uniting Forces in the Fight Against Neglected Tropical Diseases: Commemorating NTD Day"

Dear Colleagues and Partners in Global Health,

On this January 30th, we are standing together with those who suffer from Neglected Tropical Diseases (NTDs). As a network of scientists motivated by One Health principles to tackle NTDs, we join the global community in shining a light on diseases that disproportionately affect the most vulnerable populations in our world.

Recent Advances in One Health Drugs
Our concerted efforts in the realm of One Health – an integrative approach that recognizes the interconnectedness of human, animal, and environmental health – have led to significant strides in raising consciousness and combating NTDs. Recent breakthroughs in drug development and delivery systems demonstrate the potential of one-health drugs to provide more effective, sustainable, and accessible treatments for these diseases, as well as their interaction through sourcing, synthesis, localization, ecotoxicology, and resource planning.

The Imperative of Interdisciplinary Collaboration
The fight against NTDs cannot be wan in isolation. It requires a united front, bringing together experts from virology, parasitology, pharmacology, chemistry, public health, and beyond. Our network exemplifies this collaborative spirit, and we encourage continued and expanded partnerships across disciplines and borders.

Call to Action
As we commemorate this day, let us renew our commitment to eradicating NTDs. We urge the scientific community, policymakers, healthcare providers, and all stakeholders to join us in this critical mission. Together, we can make a tangible difference in the lives of those suffering from these diseases, and move closer to health equality in the world.

In Solidarity,

#OneHealthdrugs (OHD) CA21111  One Health drugs against parasitic vector borne diseases in Europe and beyond



European Cooperation in Science and Technology COST Action CA21111
 

All OneHealthdrugs network members

 

 

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi